New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Advance care planning produces trend toward less aggressive and more comfort-focused care for patients with cancer

Advance care planning produces trend toward less aggressive and more comfort-focused care for patients with cancer

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainA meta-analysis of studies involving 33,541 cancer patients evaluates the relationship between advance care planning and aggressive vs. co
Oncology January 07,2024
Advance care planning produces trend toward less aggressive and more comfort-focused care for patients with cancer

Advance care planning produces trend toward less aggressive and more comfort-focused care for patients with cancer

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainA meta-analysis of studies involving 33,541 cancer patients evaluates the relationship between advance care planning and aggressive vs. co
Oncology January 07,2024
Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study from the Italian Colorectal Cancer screening program including more than 49,000 colonoscopies found a significant
Oncology January 07,2024
Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study from the Italian Colorectal Cancer screening program including more than 49,000 colonoscopies found a significant
Oncology January 07,2024
Enhancing quality of life for brain tumor survivors

Enhancing quality of life for brain tumor survivors

by Monique Mita,Griffith UniversityGriffith School of Applied Psychology Professor Tamara Ownsworth said the Tele-Mast program aims to enhance quality of life for brain tumor survivors. Credit:
Oncology January 07,2024
Enhancing quality of life for brain tumor survivors

Enhancing quality of life for brain tumor survivors

by Monique Mita,Griffith UniversityGriffith School of Applied Psychology Professor Tamara Ownsworth said the Tele-Mast program aims to enhance quality of life for brain tumor survivors. Credit:
Oncology January 07,2024
Improving immune checkpoint inhibitors' anti-tumor response and minimizing side effects

Improving immune checkpoint inhibitors' anti-tumor response and minimizing side effects

byTohoku UniversityMetastatic lymph node targeted immune checkpoint blockade (ICB) elicits strong therapeutic response and ameliorates ICB-induced interstitial pneumonia. Credit: Tohoku Universi
Oncology January 07,2024
Improving immune checkpoint inhibitors' anti-tumor response and minimizing side effects

Improving immune checkpoint inhibitors' anti-tumor response and minimizing side effects

byTohoku UniversityMetastatic lymph node targeted immune checkpoint blockade (ICB) elicits strong therapeutic response and ameliorates ICB-induced interstitial pneumonia. Credit: Tohoku Universi
Oncology January 07,2024
Sugar modifications the key to unlocking ovarian cancer secrets

Sugar modifications the key to unlocking ovarian cancer secrets

byGriffith UniversityOvarian cancer research. Credit: Griffith UniversityThe ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and impr
Oncology January 07,2024
Sugar modifications the key to unlocking ovarian cancer secrets

Sugar modifications the key to unlocking ovarian cancer secrets

byGriffith UniversityOvarian cancer research. Credit: Griffith UniversityThe ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and impr
Oncology January 07,2024
Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainGiving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce
Oncology January 07,2024
Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainGiving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce
Oncology January 07,2024
Does diabetes mean worse outcomes for cancer patients?

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme
Oncology January 07,2024
Does diabetes mean worse outcomes for cancer patients?

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme
Oncology January 07,2024
Sugar molecules as a target in cancer therapy

Sugar molecules as a target in cancer therapy

byUniversity of BaselTherapeutic desialylation repolarizes tumor-associated macrophages (TAMs). (A) Pathway enrichment analysis performed on all macrophages between treatment conditions. UT, unt
Oncology January 07,2024
Sugar molecules as a target in cancer therapy

Sugar molecules as a target in cancer therapy

byUniversity of BaselTherapeutic desialylation repolarizes tumor-associated macrophages (TAMs). (A) Pathway enrichment analysis performed on all macrophages between treatment conditions. UT, unt
Oncology January 07,2024
Global disease burden related to nonmelanoma skin cancer explored

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh
Oncology January 07,2024
Global disease burden related to nonmelanoma skin cancer explored

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh
Oncology January 07,2024
Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim
Oncology January 07,2024
Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim
Oncology January 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com